scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0014-2999(98)00897-8 |
P698 | PubMed publication ID | 10064148 |
P50 | author | Heberto Suarez-Roca | Q44028969 |
P2093 | author name string | G Gómez | |
W Maixner | |||
G Cano | |||
J L Arcaya | |||
P2860 | cites work | The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist | Q24629716 |
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity | Q29618557 | ||
Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. | Q35039144 | ||
Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn | Q35702669 | ||
Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro | Q39244475 | ||
Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex | Q41130393 | ||
Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain | Q41200323 | ||
Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones | Q41962723 | ||
Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes | Q44332873 | ||
The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin | Q44333039 | ||
Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation | Q44335339 | ||
Kappa 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. | Q44336683 | ||
Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance | Q44336820 | ||
Multiple opioid peptides and the modulation of pain: immunohistochemical analysis of dynorphin and enkephalin in the trigeminal nucleus caudalis and spinal cord of the cat. | Q44345405 | ||
Opioid peptide immunoreactivity in spinal and trigeminal dorsal horn neurons projecting to the parabrachial nucleus in the rat. | Q44346813 | ||
Spinal dynorphin A (1-17): possible mediator of antianalgesic action | Q44797694 | ||
Spinal release of immunoreactive dynorphin A(1-8) with the development of peripheral inflammation in the rat. | Q49111477 | ||
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin | Q58493721 | ||
Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat | Q63608758 | ||
Demonstration of dynorphin A 1-8 immunoreactive axons contacting spinal cord projection neurons in a rat model of peripheral inflammation and hyperalgesia | Q67525657 | ||
Phencyclidine and sigma receptors in rat spinal cord: binding characterization and quantitative autoradiography | Q69355388 | ||
A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptor | Q69378113 | ||
Effects of traumatic injury on dynorphin immunoreactivity in spinal cord | Q69863504 | ||
Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats | Q69899455 | ||
Demonstration of calcitonin gene-related peptide immunoreactive axons contacting dynorphin A(1-8) immunoreactive spinal neurons in a rat model of peripheral inflammation and hyperalgesia | Q69929250 | ||
Distribution of chemosensitive primary sensory afferents in the central nervous system of the rat | Q71269827 | ||
Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury | Q72124402 | ||
Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat | Q72687335 | ||
Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone | Q73275114 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dynorphin | Q324076 |
substance P | Q411041 | ||
P304 | page(s) | 27-34 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | European Journal of Pharmacology | Q1376712 |
P1476 | title | Dynorphin A increases substance P release from trigeminal primary afferent C-fibers | |
P478 | volume | 366 |
Q32062786 | A biochemical model of peripheral tinnitus |
Q30491472 | Bi-phasic intensity-dependent opioid-mediated neural amplitude changes in the chinchilla cochlea: partial blockade by an N-Methyl-D-Aspartate (NMDA)-receptor antagonist |
Q82028755 | Chapter 14 Descending excitatory systems |
Q24631654 | Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia |
Q34659433 | Descending control of pain |
Q44333127 | Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. |
Q34126256 | Endogenous opiates: 1999. |
Q44580807 | Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. |
Q44209091 | Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates |
Q39391785 | Hyperalgesia: an emerging iatrogenic syndrome |
Q35152165 | Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance |
Q34152988 | Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism |
Q28252169 | Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice |
Q37553194 | Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation |
Q44762691 | Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2. |
Q33695747 | Novel strategies for pharmacotherapy of depression |
Q30752212 | Qualitative light and electron microscope study of glutamate receptors in the caudal spinal trigeminal nucleus of the rat. |
Q42524394 | Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. |
Q46572332 | Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors |
Q44037083 | Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. |
Search more.